InvestorsObserver
×
News Home

Is CV Sciences Inc (CVSI) a Laggard in the Healthcare Sector?

Monday, March 18, 2024 01:30 PM | InvestorsObserver Analysts

Mentioned in this article

Is CV Sciences Inc (CVSI) a Laggard in the Healthcare Sector?

CV Sciences Inc (CVSI) is near the bottom in its sector according to InvestorsObserver. CVSI gets an overall rating of 24. That means it scores higher than 24% of stocks. CV Sciences Inc gets a 10 rank in the Healthcare sector. Healthcare is number 2 out of 11 sectors.

Overall Score - 24
CVSI has an Overall Score of 24. Find out what this means to you and get the rest of the rankings on CVSI!

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 24 means the stock is more attractive than 24 percent of stocks. Not only are these scores easy to understand, but it is easy to compare stocks to each other. You can find the best stock in healthcare or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.

What's Happening With CV Sciences Inc Stock Today?

CV Sciences Inc (CVSI) stock is unchanged 0.76% while the S&P 500 is higher by 0.89% as of 12:48 PM on Monday, Mar 18. CVSI is unchanged $0.00 from the previous closing price of $0.03 on volume of 110,230 shares. Over the past year the S&P 500 is higher by 30.65% while CVSI is lower by -25.00%. CVSI earned $0.01 a per share in the over the last 12 months, giving it a price-to-earnings ratio of 3.11. Click Here to get the full Stock Report for CV Sciences Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App